BioHarvest Sciences Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for BioHarvest Sciences Inc. (BHST) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-12.91-12.56-11.24-9.83-6.58
Depreciation & Amortization1.250.840.710.390.29
Stock Based Compensation0.600.561.353.371.38
Change in Working Capital-0.560.76-0.31-0.10-0.23
Change in Accounts Receivable-0.31-0.26-0.16-0.17-0.18
Change in Inventory-1.19-1.09-0.45-0.83-0.05
Change in Accounts Payable1.041.510.731.00-0.11
Change in Other Working Capital-0.290.870.12-0.100.11
Other Operating Activities4.930.870.12-0.631.27
Net Cash from Operating Activities-6.68-8.52-9.24-6.79-3.88
Investing Activities
Capital Expenditures-2.84-1.47-1.26-1.64-0.17
Other Investing Activities-0.190.000.000.000.00
Net Cash from Investing Activities-3.03-1.47-1.26-1.64-0.17
Financing Activities
Debt Repayment-1.27-0.36-0.36-0.33-0.31
Common Stock Issued4.740.400.8811.104.47
Other Financing Activities0.410.00-0.040.000.00
Net Cash from Financing Activities6.7813.568.1410.774.93
Summary
Effect of Forex Changes on Cash-0.030.06-0.020.000.00
Net Change in Cash-2.973.56-2.362.330.87
Cash at Beginning of Period5.361.744.121.780.00
Cash at End of Period2.395.361.744.120.00
Free Cash Flow-9.52-10.00-10.50-8.43-4.05
Supplemental Disclosures
Interest Paid0.000.530.140.140.03